Serum Complement - Medical Science - Lecture Notes, Study notes of Biology

Serum Complement, Alternative Pathway, Membrane-Attack Complex, Complement Regulation, Decay-Accelerating Factor, Complement Receptors, Biological Consequences of Complement are some points from this lecture. In my uploads you will find many files explaining one or more basic term of Medical Science. This is introductory course for Medical Science students.

Typology: Study notes

2011/2012

Uploaded on 12/21/2012

ekmbr
ekmbr 🇮🇳

4.2

(30)

169 documents

1 / 2

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
SERUM COMPLEMENT
CLASSICAL PATHWAY: Antibody-dependent activation of complement.
INITIATION: C1 has an Fc-Receptor that is activated when IgG and/or IgM cross-link the Fc-Receptors.
o One molecule of IgM, because its pentameric is sufficient to activate complement.
o ~1000 molecules of IgG are required in order to achieve high enough concentration to get the needed cross-
linking.
C1qr2s2 then activates C4 and, separately, C2.
o C4 ------> C4a + C4b
C4a is then released as anaphylatoxin.
o C2 ------> C2a, which then catalyzes formation of C3-Convertase.
C3-CONVERTASE is then formed by C4b2a. C1 is sloughed off.
C3-Convertase then catalyzes C3 ------> C3a + C3b
o C3b then participates in both classical and alternative C5-Convertases.
o C3a is then released as anaphylatoxin.
C5-CONVERTASE is then formed by C4b2a3b
o C5 ------> C5a + C5b
C5a is released as anaphylatoxin and chemotactic factor.
C5b hooks to complement receptors and forms the initial part of the Membrane-Attack Complex
(MAC).
ALTERNATIVE PATHWAY: Antibody-independent activation of complement.
INITIATION: Initiation occurs whenever C3b and the necessary accessory enzymes are present. Alternative pathway is
subject to a positive feedback loop.
o C3 Slow Spontaneous Hydrolysis ------> C3a + C3b
o FACTOR-B ------> Ba + Bb
Ba is sloughed off.
o C3-CONVERTASE: Bb then binds to C3b to form C3bBb, which is C3-CONVERTASE.
Binding of Bb to C3b is catalyzed by FACTOR-D
The C3-Convertase is very unstable (5-min half life) unless it is stabilized by binding of
PROPERDIN.
o AMPLIFICATION / POSITIVE FEEDBACK: C3-CONVERTASE can then generate more C3b by cleaving
C3 ------> C3a + C3b
o C5-CONVERTASE: C3-Convertase (C3bBb) can bind to another C3b to form the C5-Convertase: C3bBb3b.
C5 ------> C5a + C5b
Again, C5a is given off as chemotactic factor
Again, C5b forms beginning of MAC.
MEMBRANE-ATTACK COMPLEX (MAC): C5b6789
INITIATION: C5b binds to the target-cell by means of a complement-receptor. It provides the binding site for the
subsequent addition of other factors.
C5b6 exposes hydrophobic regions of complex that nudge their way into the membrane.
C9 is a perforin-like molecule that can polymerize, and add 15 or more subunits to C5b678.
The final MAC simply pierces the membrane.
Complement Regulation:
C1 INHIBITOR (C1Inh): Glycoprotein that can block the Classical Pathway by preventing initial reaction of C1q,
preventing activation of C2 and C4.
C3-CONVERTASE REGULATORS: Family of proteins that inhibit C3-Convertase.
o CR1: Classical and Alternative C3-Convertase Inhibition. Since this is complement receptor Type-I, this acts
as a form of negative feedback.
It also acts to accelerate decay of alternative C3-Convertase.
o MEMBRANE-COFACTOR PROTEIN (MCP): Classical and Alternative C3-Convertase inhibitor.
o C4b BINDING-PROTEIN (C4bp): Classical C3-convertase inhibitor. Binds to C4b and prevents its
association with C3a, preventing formation of Classical C3-Convertase.
Docsity.com
pf2

Partial preview of the text

Download Serum Complement - Medical Science - Lecture Notes and more Study notes Biology in PDF only on Docsity!

SERUM COMPLEMENT

CLASSICAL PATHWAY: Antibody-dependent activation of complement.

  • INITIATION: C1 has an Fc-Receptor that is activated when IgG and/or IgM cross-link the Fc-Receptors. o One molecule of IgM, because its pentameric is sufficient to activate complement. o ~1000 molecules of IgG are required in order to achieve high enough concentration to get the needed cross- linking.
  • C1qr 2 s 2 then activates C4 and, separately, C2. o C4 ------> C4a + C4b  C4a is then released as anaphylatoxin. o C2 ------> C2a, which then catalyzes formation of C3-Convertase.
  • C3-CONVERTASE is then formed by C4b2a. C1 is sloughed off.
  • C3-Convertase then catalyzes C3 ------> C3a + C3b o C3b then participates in both classical and alternative C5-Convertases. o C3a is then released as anaphylatoxin.
  • C5-CONVERTASE is then formed by C4b2a3b o C5 ------> C5a + C5b  C5a is released as anaphylatoxin and chemotactic factor.  C5b hooks to complement receptors and forms the initial part of the Membrane-Attack Complex (MAC).

ALTERNATIVE PATHWAY: Antibody-independent activation of complement.

  • INITIATION: Initiation occurs whenever C3b and the necessary accessory enzymes are present. Alternative pathway is subject to a positive feedback loop. o C3 Slow Spontaneous Hydrolysis ------> C3a + C3b o FACTOR-B ------> Ba + Bb  Ba is sloughed off. o C3-CONVERTASE: Bb then binds to C3b to form C3bBb, which is C3-CONVERTASE.  Binding of Bb to C3b is catalyzed by FACTOR-D  The C3-Convertase is very unstable (5-min half life) unless it is stabilized by binding of PROPERDIN. o AMPLIFICATION / POSITIVE FEEDBACK: C3-CONVERTASE can then generate more C3b by cleaving C3 ------> C3a + C3b o C5-CONVERTASE: C3-Convertase (C3bBb) can bind to another C3b to form the C5-Convertase: C3bBb3b.  C5 ------> C5a + C5b  Again, C5a is given off as chemotactic factor  Again, C5b forms beginning of MAC.

MEMBRANE-ATTACK COMPLEX (MAC): C5b

  • INITIATION: C5b binds to the target-cell by means of a complement-receptor. It provides the binding site for the subsequent addition of other factors.
  • C5b6 exposes hydrophobic regions of complex that nudge their way into the membrane.
  • C9 is a perforin-like molecule that can polymerize, and add 15 or more subunits to C5b678.
  • The final MAC simply pierces the membrane.

Complement Regulation:

  • C1 INHIBITOR (C1Inh): Glycoprotein that can block the Classical Pathway by preventing initial reaction of C1q, preventing activation of C2 and C4.
  • C3-CONVERTASE REGULATORS: Family of proteins that inhibit C3-Convertase. o CR1: Classical and Alternative C3-Convertase Inhibition. Since this is complement receptor Type-I, this acts as a form of negative feedback.  It also acts to accelerate decay of alternative C3-Convertase. o MEMBRANE-COFACTOR PROTEIN (MCP): Classical and Alternative C3-Convertase inhibitor. o C4b BINDING-PROTEIN (C4bp): Classical C3-convertase inhibitor. Binds to C4b and prevents its association with C3a, preventing formation of Classical C3-Convertase.

Docsity.com

 It also acts to accelerate decay of alternative C3-Convertase. o DECAY-ACCELERATING FACTOR (DAF): Alternative C3-Convertase inhibitor. It accelerates the decay of C3-Convertase (which has a short half-life without properdin), thereby effectively inhibiting the alternative pathway. o FACTOR-H: Prevents the association between C3b and Factor-B  It also acts to accelerate decay of alternative C3-Convertase.  FACTOR-I: In all these cases, factor cleaves the dissociated (decayed) C3-Convertase, to disable it and prevent it from reassembling.

  • CD-59: Inhibits the MAC. It binds to C8, preventing the polymerized assembly of C9.
  • ANAPHYLATOXIN INACTIVATOR (AI): Inactivates C3a, C4a, and C5a by cleaving an Arg residue from them.

COMPLEMENT RECEPTORS:

  • CR1: Has a high affinity for C3b, to form the MAC. o Also plays an important role in regulating complement cascade (see above).
  • CR2: Limited to B-Cells and some T-Cells. Function unknown.
  • CR3 / CR4: Found on natural immunity cells (monocytes, PMN's, NK's)
  • C3a, C4a, C5a Anaphylatoxin Receptors: Mast cells and Basophils have anaphylatoxin receptors which effect degranulation when bound.

Biological Consequences of Complement:

  • Cell Lysis (via MAC): o Enveloped viruses are susceptible. o Most or all gram-negative bacteria  Resistant strains of E. Coli and Salmonella exist, associated with the smooth bacterial phenotype. o Streptococcus Pneumoniae is resistant to complement, due to its capsule.
  • Anaphylaxis: C3a, C4a, C5a are the Anaphylatoxins o Smooth muscle contraction (bronchoconstriction) o Increased vascular permeability (endothelial cell constriction) o Adhesion of neutrophils to vascular endothelia (extravasation) o C5a is the most potent of all in mediating these effects.
  • Chemotaxis: C5a is Chemotactic Factor. Very strongly chemotactic for neutrophils
  • Opsonophagocytosis: C3b is an opsonin. o Phagocytes (Neutrophils, Macrophages, NK-Cells) express complement receptors (CR1, CR3, CR4) that bind C3b and thereby facilitate phagocytosis.
  • Clearance and Solubilization of Immune Complexes: o SLE: In Lupus it was found that complement deficiencies can predispose you to Lupus, suggesting that complement plays a role in immune-complex clearance.  Specific deficiencies are the precursors of C3b -- C1, C2, and C4. o MECH: Coating of immune complexes with C3b is thought to facilitate its binding to CR1 on RBC's.

COMPLEMENT DEFICIENCIES:

  • HEREDITARY ANGIO-EDEMA (HAE): Genetic inability to produce C1Inh o SYMPTOMS: Swelling of arteries. o PATHOPHYSIOLOGY: Defective C1Inh leads to a hyperactive classical pathway ------> C2-kinin split products ------> vascular permeability and angioedema.
  • PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH): Defect in CD59 and DAF inhibitors. o CD59 and DAF are alpha-adrenergic (IP 3 ) linked proteins. o SYMPTOM = hemolytic anemia.
  • Early Component Deficiencies: Lead Type-III Immune Complex diseases such as Lupus.
  • C3-DEFICIENCIES: Lead to disseminated Neisseria Gonorrhea, as Neisseria proliferate in the absence of complement defense. o Neisseria = gram-neg bacteria.
  • LEUKOCYTE ADHESION DISEASE (LAD): Abnormal beta-Chain of Integrin molecule, resulting in deficient immunity. o Susceptibility to bacterial infections. o Poor wound healing.

Docsity.com